Pharmacyclics Reports First Quarter Fiscal 2009 Financi...(88 Other noncurrent assets ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
Date:10/30/2008
88
Other noncurrent assets 290 523
$13,932 $18,367
Liabilities and stockholders' equity
Current liabilities $2,160 $1,851
Long-term obligations 70 71
Stockholder's equity 11,702 16,445
$13,932 $18,367
* Marketable securities $5,679 $4,495
'/>"/>
| SOURCE Pharmacyclics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
2. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
3. Pharmacyclics Announces It Received Nasdaq Notification
4. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
5. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. United Therapeutics Reports Third Quarter 2008 Financial Results
8. BioMed Realty Trust Reports Third Quarter 2008 Financial Results
9. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
10. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
Breaking Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3
[0] Martek Signs Sole-Source Supply Agreement with Fonterra[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES[0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years[0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner
Other Biology Technology:Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 2Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas 3Novel compound may treat acute diarrhea 2Novel compound may treat acute diarrhea 3Novel compound may treat acute diarrhea 4Novel compound may treat acute diarrhea 5Michigan Tech scientist models molecular switch 2
Breaking Biology News(10 mins):Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2Scientists identify natural anti-cancer defenses 2Simulation helps students learn dental implant procedures 48631 1Simulation helps students learn dental implant procedures 48631 2Simulation helps students learn dental implant procedures 48631 3Wii hab may enhance Parkinsons treatment 48629 1Wii hab may enhance Parkinsons treatment 48629 2Coloradoans Love Affair with Giving Grows 21 48627 1Coloradoans Love Affair with Giving Grows 21 48627 2
Other Biology News:Mass. General study shows how exercise changes structure and function of heart 2Government, Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security, Surveillance 2Government, Industry Leaders Come Together to Explore Technology Alternatives to Border Fence for Security, Surveillance 3Mascoma and UT join in $26M DOE grant 2Mascoma and UT join in $26M DOE grant 3
Biology Products:
Rabbit Anti-Bovine Xanthine Oxidase, Buttermilk Polyclonal Antibody, Unconjugated from Meridian Life Science, Inc.Mouse Anti-Human QPRT Polyclonal Antibody, Unconjugated from Novus BiologicalsFailSafe PCR PreMix Selection Kit from EPICENTRE BiotechnologiesShields and Sang M3 Insect Medium from Sigma-Aldrich
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |